Ventura Capital Research
Investment Thesis
Ventura Capital is a growth-stage, pre-IPO technology investor founded in 2012 by Mo El Husseiny. The firm's model is deliberately non-traditional: it operates on a deal-by-deal basis rather than raising a blind-pool fund, and does not charge annual management fees. Ventura is highly selective, focusing on disruptive technology companies that are growing rapidly and have a credible plan to reach an IPO within two to four years. Formally, all references to "Ventura Capital" refer to Ventura Capital GP Limited, a Cayman Islands entity, with an FCA-regulated advisory arm (Ventura Group Holding Limited, an appointed representative of Sapia Partners LLP) operating out of London.
The team describes its culture as proactive: Ventura creates and leads its own investment opportunities rather than waiting for inbound deal flow, and evaluates opportunities on the credibility of the growth plan, management's ability to execute, and valuation discipline. Ventura invests after technical and commercial proof points are established, backing "scaling executors" with an attractive risk/reward profile at the growth stage rather than early-stage bets.
Stage Focus
Ventura invests exclusively at the growth stage, post product-market fit, post technical and commercial validation, with a company already on a credible multi-year path to IPO. This is not a seed or Series A investor.
Check Size
No fixed check-size range is published. Deal sizes across recent rounds it has participated in or led span roughly $20M (StirlingX Series A) to $165M (Upgrade equity round) and $400M+ (Tekever's UK growth program), reflecting a growth/late-stage, deal-by-deal mandate rather than a fixed ticket band.
Lead Tendency
Ventura frequently leads or co-leads the rounds it participates in, for example, it led Owlstone Medical's Series E financing and co-led GALLOS Technologies' balance-sheet raise alongside Aberdeen Investments.
Recent Activity
Ventura has been active across 2025-2026 with a cluster of defence-tech, fintech, and healthtech deals: GALLOS Technologies ($50M, August 2026), StirlingX ($20M Series A, June 2026), Allica Bank ($155M Series D, February 2026), ManageMy ($45M, February 2026), Tekever's £400M UK OVERMATCH defence program (May 2025), Upgrade ($165M equity round, October 2025), and Owlstone Medical ($27M Series E, January 2025). This cadence indicates an actively deploying, generalist growth investor with a current tilt toward European and UK defence/security technology alongside its long-standing fintech book.
Portfolio Highlights
To date the firm states it has deployed over $1 billion across leading growth-stage companies. Historic marquee names cited by the firm include Allica Bank, Tekever, Upgrade, Zilch, Coursera, Spotify, Delos, Xiaomi, Twitter, Nextdoor, Alibaba, Lookout Mobile Security, Auto1, Uber, and Lyft, several of which have since gone public or been acquired. Current active portfolio spans fintech (Allica Bank, Equals Money/Railsr, Nomupay, Sipay, Neo Financial, Plum, Invstr), defence and security technology (Tekever, GALLOS Technologies, StirlingX, Senseon), space (Umbra Space), healthtech (Owlstone Medical, Rain Stella Technologies), insurtech (ManageMy), sports technology (Playermaker), and logistics software (Supermove).
Team
- Mo El Husseiny, Founder & Managing Partner. Founded Ventura in 2012; previously Group Strategy Director and Head of Special Projects at Mubadala Development Company (executed $15B+ of investments), and worked at Goldman Sachs in the Industrials and Natural Resources Division in London.
- Tom Grant, CFA, Partner. Joined from Aviva Investors, where he was Head of Venture & Growth Investments managing $3B in listed equity and private capital. CFA Charterholder; BSc Natural Sciences, Durham University.
- Joey D. Barnett, Partner (joined 2024). Over a decade in alternative investments spanning venture capital, real estate, and entrepreneurship, including founding a fintech startup.
- James Amos, Partner. 18+ years in financial roles including at Mubadala's finance leadership team and EY's transactions advisory practice; MBA, London Business School.
- Daniel Jeon, Partner. 18+ years as an M&A, corporate and securities lawyer (Allen & Overy UAE, Goodmans LLP Toronto); leads structuring of Ventura's investment transactions from Dubai.
- Carrie Newman, Group Financial Controller. Over a decade in venture capital and private equity fund finance, previously at Amadeus Capital Partners.
- Cristina Merino, Financial Controller. 15+ years in business management, operations, and Big Four advisory/audit practices across EMEA.
- Lord Philip Hammond of Runnymede, PC, Chair of the Ventura Advisory Board. Former UK Chancellor of the Exchequer, Foreign Secretary and Defence Secretary; sits on the boards of portfolio companies Tekever and Equals-Railsr (as Chair).
The Advisory Board also includes Sir William Russell (former Lord Mayor of the City of London), Rod Paris (former Group CIO of Standard Life Aberdeen), Stefan Keitel (former CEO, Deka Investment / Harald Quandt Holding), Ellecia Saffron (Founder, Maysaffron), Dr. Alexander Landia, and Brian Edelman.
Decision Process
Ventura operates as a partnership of investment professionals (Managing Partner plus multiple Partners) rather than a solo-GP structure, supported by a senior advisory board with deep institutional and public-sector credibility (a former UK Chancellor, a former FTSE 100 CIO, a former Lord Mayor of London).
Founder Preferences
Ventura backs "scaling executers", management teams that have already proven technical and commercial viability and can demonstrate a credible, well-governed path to an IPO within 2-4 years, rather than pre-product or unproven teams.
Geographic Focus
Headquartered in London (Mayfair) with a second office in Dubai (DIFC), giving Ventura strong access to both European/UK deal flow and Gulf institutional capital. Its portfolio spans the UK, wider Europe, the Middle East, and North America (e.g., Upgrade and Neo Financial in the US/Canada).